Yes, a coronary calcium CT scan would be beneficial in this patient with elevated lipoprotein(a) of 51 mg/dL.
Given your elevated Lp(a) level of 51 mg/dL (above the 50 mg/dL threshold), you should undergo coronary artery calcium (CAC) scoring to guide treatment intensity, particularly if you fall into the borderline-to-intermediate cardiovascular risk category (5-20% 10-year ASCVD risk). 1
Why CAC Scoring is Recommended for Elevated Lp(a)
The 2020 Endocrine Society Clinical Practice Guidelines explicitly identify elevated Lp(a) ≥50 mg/dL as a risk-enhancing factor that justifies advanced risk assessment with CAC scoring 1. The 2018 AHA/ACC Cholesterol Guidelines similarly endorse CAC testing (Class IIA recommendation) in patients at borderline-to-intermediate risk with risk-enhancing factors, which includes elevated Lp(a) 1.
The Evidence Supporting This Approach
CAC scoring is the single best test for improving cardiovascular risk assessment, outperforming all other advanced risk assessment strategies including carotid ultrasound and inflammatory markers 1. It provides the largest improvements in risk prediction (C-statistic change 0.05) and the highest net reclassification improvement values (0.60 in intermediate risk patients) 1.
Recent multicohort research from 2026 demonstrates that Lp(a) and CAC are independently associated with cardiovascular risk 2, 3. Critically, elevated Lp(a) increases risk across all CAC strata:
- CAC = 0 with Lp(a) >50 mg/dL: Event rate 4.9 vs 3.8 per 1,000 person-years (HR 1.28) 2
- CAC >0 with Lp(a) >50 mg/dL: Event rate 21.2 vs 18.2 per 1,000 person-years (HR 3.03) 2
- CAC ≥300 with Lp(a) >50 mg/dL: Highest risk group (HR 6.12) 2
How to Use the CAC Score Results
The CAC score will directly inform your treatment strategy 1:
CAC = 0 (Zero Score)
- Reclassifies you to lower risk
- Less aggressive lipid therapy may be appropriate
- However, do not down-classify if you smoke, have diabetes, or have a family history of premature coronary disease 1, 4
- Even with CAC = 0 and elevated Lp(a), absolute event rates remain low but still elevated compared to normal Lp(a) 2
- Consider repeat CAC in 5-7 years for low-risk patients, 3-5 years for borderline-to-intermediate risk 1
CAC = 1-99
- Favors statin therapy, especially if you're over age 55 5, 4
- Warrants a renewed risk discussion with your physician
- Consider repeat CAC in 5 years if initially untreated 4
CAC ≥100 or ≥75th percentile for age/sex/race
- Move to higher-risk category
- Initiate or intensify statin therapy with or without non-statin therapies to achieve lower LDL-C targets 1
- Treat more aggressively given the combination of elevated Lp(a) and significant coronary calcification 2
CAC ≥300-400
- Very high risk, equivalent to secondary prevention
- Requires aggressive lipid-lowering therapy 6
- With elevated Lp(a), this represents the highest risk group 2
Important Caveats
Lp(a) is associated with non-calcified plaque progression 7, 8, meaning CAC may underestimate total plaque burden in patients with elevated Lp(a). However, CAC scoring remains a powerful risk stratification tool even in this population 2. The test takes only 10-15 minutes with minimal radiation exposure (~1 mSv, similar to a bilateral mammogram) 1.
Do not use CAC as the sole deciding factor for treatment intensity if you have conditions present from a young age (severe obesity, diabetes) where early non-calcified plaque may exist 1. In these cases, aggressive lipid lowering should continue regardless of CAC score.
The Bottom Line
Your Lp(a) of 51 mg/dL places you above the guideline threshold of 50 mg/dL, making you a candidate for CAC scoring to personalize your cardiovascular risk assessment and treatment strategy. The combination of elevated Lp(a) and CAC provides independent and additive risk information that cannot be obtained from traditional risk calculators alone 2, 3. This will allow for more precise targeting of preventive therapies based on your actual atherosclerotic burden rather than estimated risk alone.